Showing results (211-220 of 369) with videos related to
Sort By:
Pageof 37
Radiation Research|June 8, 2017
Rapid Prediction of Hematologic Acute Radiation Syndrome in Radiation Injury Patients Using Peripheral Blood Cell CountsM Port, B Pieper, T Knie, et al.World Journal of Urology|January 25, 2011
Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patientsC Seidel, M Fenner, A S Merseburger, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Complete response of a gastric primary after a short but toxic course of 'S-1' EORTC Early Clinical Studies GroupP Schöffski, P Chollet, A Ganser, et al.British Journal of Haematology|March 1, 1995
Changes in erythroid progenitor cell and accessory cell compartments in patients with myelodysplastic syndromes during treatment with all-trans retinoic acid and haemopoietic growth factorsA B Maurer, A Ganser, G Seipelt, et al.Research in Virology|March 1, 1991
Infection of granulocyte/monocyte progenitor cells with HIV1G Kojouharoff, O G Ottmann, H von Briesen, et al.European Journal of Cancer (Oxford, England : 1990)|May 26, 2005
Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumoursP Schöffski, I Breidenbach, J Krauter, et al.Genes, Chromosomes & Cancer|March 1, 1995
Comparative genomic hybridization in the investigation of myeloid leukemiasM Bentz, H Döhner, K Huck, et al.Acta Haematologica|October 30, 1998
Fluorescence in situ hybridization and surface markers of fine needle aspiration specimen confirm extramedullary myeloblastoma in a patient with chronic myeloid leukemiaM Karthaus, J G Meran, L Wilkens, et al.Leukemia & Lymphoma|July 1, 1996
Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocationM Nolte, M Werner, M Ewig, et al.Biotechnology Therapeutics|January 1, 1991
Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndromeF Herrmann, R Mertelsmann, A Lindemann, et al.Pageof 37